肠道微生物群和便秘之间的因果关系:一个双向的门德尔随机化研究
Cuncheng Feng1, Guanzhuang Gao1, Kai Wu1
1Department of Gastrointestinal Surgery, The Affiliated Changzhou No. 2 People's Hospital of Nanjing Medical University, Changzhou, China.
Frontiers in microbiology
|August 1, 2024
概括
这项研究揭示了肠道微生物群和便秘之间的双向关系. 某些细菌,如Coprococcus,可以防止便秘,而其他细菌则会增加风险,便秘也会影响细菌的组成.
科学领域:
- 胃肠道学和微生物学
- 人类遗传学 人类遗传学
- 计算生物学 计算生物学
背景情况:
- 便秘影响全球15%的人口,造成严重的健康负担.
- 肠道微生物群越来越多地与便秘有关,但因果关系尚不清楚.
- 观察性研究受到混因素和潜在的反向因果关系的限制.
研究的目的:
- 调查肠道微生物群和便秘之间的因果关系.
- 使用双向门德尔随机化 (MR) 方法来解决混和反向因果关系.
- 为了确定与便秘风险因果相关的特定细菌种群.
主要方法:
- 使用来自MiBioGen和其他联盟的全基因组关联研究 (GWAS) 数据.
- 作为196种细菌特征和便秘的仪器变量 (IVs) 选择的遗传变异.
- 应用多种MR方法 (IVW,MR Egger,MR-PRESSO) 进行可靠的因果推断.
主要成果:
- 鉴定出具有抗便秘保护作用的特定细菌 (例如,Coprococcus1,Coprococcus3,Desulfovibrio,Flavonifractor,Lachnospiraceae UCG004),这些细菌可以帮助预防便秘.
- 发现了与便秘风险增加相关的其他细菌 (例如,鲁米诺科卡ceae UCG005,Eubacterium nodatum群,Butyricimonas,Bacteroidetes).
- 证明了双向关系,便秘改变了诸如Family XIII,Porphyromonadaceae和Proteobacteria之类的种群的丰富性.
结论:
- 肠道微生物群和便秘表现出一种复杂的,双向的遗传相互作用.
- 特定的细菌种类在便秘的发展或预防中起着因果作用.
- 这些发现突出了肠道微生物组中的潜在治疗点,用于便秘管理.
相关概念视频
Anatomy of the Intestines
71.7K
Although digestion of proteins, carbohydrates, and lipids may begin in the stomach, it is completed in the intestine. The absorption of nutrients, water, and electrolytes from food and drink also occurs in the intestine. The intestines can be divided into two structurally distinct organs—the small and large intestines.
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the...
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the...
71.7K
Irritable Bowel Syndrome I: Introduction
264
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
264
Drugs for Treatment of Constipation-Predominant IBS
151
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
151
Bacterial Flora of the Large Intestine
408
The gut microbiome is formed by a vast and diverse community of bacteria that colonizes our large intestine. These bacteria start residing in the gut from birth and continue diversifying throughout life, influenced by factors such as diet, lifestyle, and stress. The gut bacterial community also includes bacteria from food and those that enter the colon through the anus.
The normal gut flora of the colon plays a critical role in generating essential vitamins such as vitamins K, B5, and B7.
The normal gut flora of the colon plays a critical role in generating essential vitamins such as vitamins K, B5, and B7.
408


